EleftheriosMylonakisMD

Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Dr. Mylonakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6550 Fannin St
Ste 1001
Houston, TX 77030
Phone+1 617-670-9115

Fax+1 713-790-2797

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1999 - 2003
Brown UniversityResidency, Internal Medicine, 1995 - 1999
University of AthensClass of 1990

PubMed

9 citations
Clinical Outcomes of Adult Patients Hospitalized with COVID-19 after Vaccination.
Markos Kalligeros, Fadi Shehadeh, Evangelia K. Mylona, Matthew Kaczynski, Saisanjana Kalagara
Tropical Medicine and Infectious Disease. 2021-09-26
337 citations
The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis
Tristan T Timbrook, Jacob B. Morton, Kevin W. McConeghy, Aisling R. Caffrey, Eleftherios Mylonakis
Clinical Infectious Diseases. 2017-01-01
121 citations
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspecti...
John W. Baddley, F. Cantini, Delia Goletti, Juan J. Gomez-Reino, E. Mylonakis
Clinical Microbiology and Infection. 2018-06-01

Journal Articles

The Cost-Effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections
Elina Eleftheria Pliakos, Nikolaos Andreatos, Eleftherios Mylonakis, Clinical Infectious Diseases
The Global Alliance for Infections in Surgery: Defining a Model for Antimicrobial Stewardship—Results from an International Cross-Sectional Survey
Richard R Watkins, Eleftherios Mylonakis, Robert G Sawyer, Costi D Sifri, BioMed Central

FDA Committee OKs Modifying Boosters; Challenges Ahead for ManufacturersJune 29th, 2022
Coronavirus Chronicles — Hitting Kids HardDecember 30th, 2021
Experimental Pill Could Be ‘Game Changer’ in Treating COVID-19, RI Doctors SayNovember 5th, 2021
Join now to see all